| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 23:21:14 UTC |
|---|
| Update Date | 2021-09-26 22:55:20 UTC |
|---|
| HMDB ID | HMDB0246326 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 4-Acetamidoantipyrine |
|---|
| Description | 4-Acetamidoantipyrine belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. 4-Acetamidoantipyrine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a small amount of articles have been published on 4-Acetamidoantipyrine. This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-acetamidoantipyrine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-Acetamidoantipyrine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CN1N(C(=O)C(NC(C)=O)=C1C)C1=CC=CC=C1 InChI=1S/C13H15N3O2/c1-9-12(14-10(2)17)13(18)16(15(9)3)11-7-5-4-6-8-11/h4-8H,1-3H3,(H,14,17) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Acetaminoantipyrine | ChEBI | | 4-Acetoaminoantipyrine | ChEBI | | Acetylaminoantipyrine | ChEBI | | 4-Acetylaminoantipyrine | HMDB | | N-Acetylaminoantipyrine | HMDB |
|
|---|
| Chemical Formula | C13H15N3O2 |
|---|
| Average Molecular Weight | 245.282 |
|---|
| Monoisotopic Molecular Weight | 245.116426735 |
|---|
| IUPAC Name | N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)acetamide |
|---|
| Traditional Name | N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)acetamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN1N(C(=O)C(NC(C)=O)=C1C)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C13H15N3O2/c1-9-12(14-10(2)17)13(18)16(15(9)3)11-7-5-4-6-8-11/h4-8H,1-3H3,(H,14,17) |
|---|
| InChI Key | OIAGWXKSCXPNNZ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Azoles |
|---|
| Sub Class | Pyrazoles |
|---|
| Direct Parent | Phenylpyrazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylpyrazole
- N-acetylarylamine
- N-arylamide
- Monocyclic benzene moiety
- Pyrazolinone
- Benzenoid
- Vinylogous amide
- Acetamide
- Heteroaromatic compound
- Secondary carboxylic acid amide
- Lactam
- Carboxamide group
- Carboxylic acid derivative
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 9.6944 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.76 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1026.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 223.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 107.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 159.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 48.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 250.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 322.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 144.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 657.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 195.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 761.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 216.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 202.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 337.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 282.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 255.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 4-Acetamidoantipyrine,1TMS,isomer #1 | CC(=O)N(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)[Si](C)(C)C | 2055.5 | Semi standard non polar | 33892256 | | 4-Acetamidoantipyrine,1TMS,isomer #1 | CC(=O)N(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)[Si](C)(C)C | 2139.9 | Standard non polar | 33892256 | | 4-Acetamidoantipyrine,1TMS,isomer #1 | CC(=O)N(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)[Si](C)(C)C | 2669.5 | Standard polar | 33892256 | | 4-Acetamidoantipyrine,1TBDMS,isomer #1 | CC(=O)N(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C | 2299.5 | Semi standard non polar | 33892256 | | 4-Acetamidoantipyrine,1TBDMS,isomer #1 | CC(=O)N(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C | 2300.1 | Standard non polar | 33892256 | | 4-Acetamidoantipyrine,1TBDMS,isomer #1 | CC(=O)N(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)[Si](C)(C)C(C)(C)C | 2775.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 4-Acetamidoantipyrine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0g59-4790000000-417ba707efc84a6c6819 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Acetamidoantipyrine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 40V, Positive-QTOF | splash10-008c-0900000000-83d1ff371690052cd487 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 30V, Positive-QTOF | splash10-0pdi-0940000000-a201ff2640a0846849f6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 35V, Positive-QTOF | splash10-004i-0090000000-4c363f26ce86c080f001 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 55V, Positive-QTOF | splash10-0ue9-8930000000-eb8143bff273a8db7798 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 35V, Positive-QTOF | splash10-004i-0090000000-bd9038de40e6acd6eb17 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 50V, Positive-QTOF | splash10-000x-0900000000-1dea69f3926567adba08 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 50V, Positive-QTOF | splash10-000y-0900000000-37b8823300f3e09834b7 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 15V, Positive-QTOF | splash10-0002-0090000000-af268200b0790a435d11 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 30V, Positive-QTOF | splash10-004i-0090000000-2d4ba29a325b9d43cfc5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 50V, Positive-QTOF | splash10-000y-0900000000-d6c698034db599229f4d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 55V, Positive-QTOF | splash10-004i-0090000000-a4a4f5dfb098dd89c29e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 75V, Positive-QTOF | splash10-0f89-9400000000-f1581e7c5ac2bcb8f2b1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 90V, Positive-QTOF | splash10-001i-9300000000-ec7e2dc85de9c3496bd1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 60V, Positive-QTOF | splash10-0f89-9710000000-a7bf7cfd48b545d5e50a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 60V, Positive-QTOF | splash10-0f89-9710000000-182468fbdca0a365bf45 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 35V, Positive-QTOF | splash10-004i-0090000000-0f8953497229fa1abf63 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 80V, Positive-QTOF | splash10-0f89-9500000000-0fc52f6ab12fe8d5642d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 45V, Positive-QTOF | splash10-0ugi-4590000000-f6589ce3610926578197 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Acetamidoantipyrine 45V, Positive-QTOF | splash10-0ugi-5590000000-54756eefc4b6e984ecdb | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Acetamidoantipyrine 10V, Positive-QTOF | splash10-0f6t-0190000000-d1aae307767141af1cab | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Acetamidoantipyrine 20V, Positive-QTOF | splash10-0pb9-9160000000-4454599ea3f9778d48ef | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Acetamidoantipyrine 40V, Positive-QTOF | splash10-0f89-9100000000-ffc177034f7186be61bb | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Acetamidoantipyrine 10V, Negative-QTOF | splash10-00dl-4930000000-22e4c8d8af84a4e1bfca | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Acetamidoantipyrine 20V, Negative-QTOF | splash10-0udl-7980000000-53b7e76538554032ec7f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Acetamidoantipyrine 40V, Negative-QTOF | splash10-0006-9300000000-b2ebf7079001e3a1b0d7 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
|---|